louisiana semaglutide gi obstruction legal team Ozempic Lawsuit louisiana semaglutide gastrointestinal obstruction legal

Analysis of nearly 8,000 adults found 45% keep the weight off after one year

Pfizers dose-optimization studies of once-daily formulations of danuglipron ( NCT06567327 and NCT06568731 ) met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase 3 testing, based on earlier studies of twice-daily danuglipron

Proper storage temperature is critical for maintaining GLP-1 injection stability and efficacy

com can reveal a powerful mix of personal insecurity and persistent body-shaming pushed Serena Williams toward using weight-loss injections to shed 31lbs, a decision following years of scrutiny that left lasting scars on the tennis icon.